Newtor Health Care

MYDEKLA 60MG TABLET contains Daclatasvir which belongs to the group of medicines called Antiviral agents. It is used with sofosbuvir (with/without) ribavirin to treat chronic hepatitis C virus (genotype 1 or 3) infection in affected individuals.
Hepatitis C is a liver infection which occurs due to contact with hepatitis C virus which spreads in a healthy person due to contact with blood of an infected person. It is generally characterized by symptoms such as bloating, fluid in the abdomen, nausea, fatigue, fever, and/or loss of appetite.
MYDEKLA 60MG TABLET is not recommended for use if you are allergic to Daclatasvir. Before taking MYDEKLA 60MG TABLET, inform your doctor if you have heart problems, liver problems (such as history of hepatitis B infection, liver transplant, mild, moderate, severe hepatic impairment) and end-stage renal disease.
MYDEKLA 60MG TABLET is not recommended for use during pregnancy and in breastfeeding women as it may pass through milk. It is not known whether this medicine is safe and effective in children and adolescents below 18 years of age. Consult your doctor before taking the medicine.
The most common side effects associated with the use of MYDEKLA 60MG TABLET are headache, anaemia, tiredness, nausea, diarrhoea, rash, and sleeplessness. Consult your doctor before taking the medicine.
USES OF MYDEKLA 60MG TABLET

Used with sofosbuvir (with/without) ribavirin to treat chronic hepatitis C virus (genotype 1 or 3) infection in affected individuals

Ledipasvir Sofosbuvir Tablets 45 mg are antiviral medicines used in the treatment of chronic hepatitis C virus (HCV) infection under medical supervision. This combination contains Ledipasvir 45 mg and Sofosbuvir, which work together to inhibit viral replication at different stages of the HCV life cycle. Ledipasvir acts as an NS5A inhibitor, while Sofosbuvir is a nucleotide analogue NS5B polymerase inhibitor, making this combination highly effective in managing hepatitis C infection.

Ledipasvir Sofosbuvir tablets are widely prescribed in hepatology and infectious disease treatment due to their high cure rates and favorable safety profile. International buyers frequently search for this product using terms such as Ledipasvir Sofosbuvir tablets exporter, hepatitis C treatment tablets supplier, HCV antiviral medicine wholesale, Ledipasvir Sofosbuvir combination tablets, hepatitis C drug exporter from India, and antiviral medicines supplier. Due to strong global demand for hepatitis C treatment, this combination remains a key product in international pharmaceutical markets.

Manufactured in accordance with international pharmaceutical quality standards, Ledipasvir Sofosbuvir Tablets 45 mg comply with IP, BP, or USP specifications as applicable. The tablets are supplied in original, sealed, export-quality packaging suitable for hospital use and international pharmaceutical distribution. Importers prefer sourcing hepatitis C medicines from trusted exporters who provide authentic products with complete regulatory documentation.

Applications
Ledipasvir Sofosbuvir Tablets 45 mg are supplied to hospitals, gastroenterology clinics, liver care centers, infectious disease clinics, and pharmaceutical distribution networks. They are commonly procured by hospital pharmacies, medical wholesalers, and international importers dealing in antiviral and hepatitis medicines. The product is intended strictly for use under the supervision of qualified healthcare professionals.

Usage & Storage
Ledipasvir Sofosbuvir Tablets 45 mg should be used strictly as prescribed by a licensed medical practitioner. Dosage and duration of therapy depend on the patient's clinical condition and HCV genotype. Tablets should be stored in a cool, dry place away from direct sunlight and moisture to maintain stability during storage and international transport.

Export & Supply
Narix Pharmaceuticals Pvt Ltd is a trusted exporter and supplier of Ledipasvir Sofosbuvir Tablets 45 mg from India, supplying genuine hepatitis C antiviral medicines to international buyers. We export Ledipasvir Sofosbuvir tablets to markets including USA, UK, Australia, Vietnam, Singapore, and other global destinations. Our company supports pharmaceutical importers, hospital suppliers, and distributors seeking reliable sources of hepatitis C treatment medicines from India.

Narix Pharmaceuticals Pvt Ltd provides complete export documentation, secure packaging, and dependable logistics support in compliance with international trade requirements. We support bulk supply, consistent availability, and long-term partnerships with competitive export pricing.

Why Choose Us
Buyers searching for Ledipasvir Sofosbuvir Tablets 45 mg exporter, hepatitis C medicine supplier India, HCV antiviral tablets wholesale, Ledipasvir Sofosbuvir combination exporter, or pharmaceutical antiviral medicines exporter can rely on Narix Pharmaceuticals Pvt Ltd for authentic products, consistent quality, timely dispatch, and professional export service. Our strong focus on quality assurance, regulatory compliance, and global pharmaceutical supply makes us a dependable partner for Ledipasvir Sofosbuvir tablet exports worldwide.